Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 2Cholangiocarcinoma 2Acrocephalosyndactylia 2Urinary Bladder Neoplasms 1Upper Tract Urothelial Carcinomas 1Tumor With Alterations of the FGF-R 1Melanoma 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

pemigatinib 6infigratinib 2erdafitinib 2derazantinib 2pembrolizumab 1exemestane 1atezolizumab 1Rogaratinib 1INCB 54828-101 1Gemcitabine 1Fulvestrant 1Drug Combinations 1Carboplatin 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Acrocephalosyndactylia × infigratinib × Clear all
NCT05019794 2022-06-27

FGFR

LianBio LLC

Phase 2 Unknown
80 enrolled
Gastrointestinal

Acrocephalosyndactylia, Stomach Neoplasms

NCT01928459 2020-12-09

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Novartis

Phase 1 Completed
62 enrolled
Breast

Acrocephalosyndactylia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡